Park Square has placed Amanda Kay, Ph.D., as Chief Business Officer at Deep Genomics.
Deep Genomics, the leading artificial intelligence (AI) therapeutics company, announced today the appointment of Amanda Kay, Ph.D., to the newly created role of Chief Business Officer.